iSpecimen
Stock Forecast, Prediction & Price Target

iSpecimen Financial Estimates

iSpecimen Revenue Estimates

iSpecimen EBITDA Estimates

iSpecimen Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$11.13M
 
N/A
$10.40M
 
-6.58%
$9.92M
 
-4.55%
Avg: $12.70M
Low: $12.70M
High: $12.70M
avg. 27.92%
Avg: $14.60M
Low: $14.60M
High: $14.60M
avg. 14.99%
Net Income
 
% change YoY
$-10.01M
 
N/A
$-9.04M
 
9.73%
$-11.09M
 
-22.77%
Avg: $-13.53M
Low: $-10.39M
High: $-10.39M
avg. -21.94%
Avg: $0
Low: $0
High: $0
avg. 100%
EBITDA
 
% change YoY
$-5.95M
 
N/A
$-10.00M
 
-67.94%
$-9.10M
 
9.02%
Avg: $-8.43M
Low: $-8.43M
High: $-8.43M
avg. 7.30%
Avg: $-9.70M
Low: $-9.70M
High: $-9.70M
avg. -14.99%
EPS
 
% change YoY
-$1.15
 
N/A
-$1.02
 
11.30%
-$1.23
 
-20.58%
Avg: -$1.15
Low: -$1.15
High: -$1.15
avg. 6.50%
Avg: $0
Low: $0
High: $0
avg. 100%
Operating Expenses
 
% change YoY
$11.81M
 
N/A
$15.83M
 
34.03%
$16.27M
 
2.81%
Avg: $11.72M
Low: $11.72M
High: $11.72M
avg. -27.97%
Avg: $13.48M
Low: $13.48M
High: $13.48M
avg. 14.99%

FAQ

What is iSpecimen stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -10.97% in 2025-2026.

We have gathered data from 1 analysts. Their low estimate is -10.39M, average is -13.53M and high is -10.39M.

What is iSpecimen stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 21.46% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $12.70M, average is $12.70M and high is $12.70M.

What is iSpecimen stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 3.25% in 2025-2026.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.15, average is -$1.15 and high is $-1.15.